Emergency help for low blood sugar

MIT engineers have developed an implantable device, the size of a quarter, to combat hypoglycemia in type 1 diabetes patients. The device contains powdered glucagon and can be remotely activated to release the drug when needed. It aims to provide a more efficient and automatic solution for low blood sugar episodes, especially during sleep or for patients who cannot self-inject. The device, successfully tested in mice, could also potentially be used to deliver epinephrine for heart attacks or anaphylactic shock.